UPDATED May 01, 2024
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IDD | €2.20 | -0.9% | -12.7% | €178.3m | €6.24 | PS2.9x | E33.0% | n/a | ||
P0F | kr0.52 | 2.0% | -24.0% | kr1.9b | kr1.07 | PS32.4x | E85.4% | n/a | ||
51KA | US$7.95 | -4.8% | -43.6% | US$216.7m | US$24.51 | PS4.3x | E62.0% | n/a | ||
41X | US$6.09 | 3.0% | 53.7% | US$1.5b | US$12.74 | PS12x | E59.6% | n/a | ||
OL0 | kr8.10 | -6.0% | 16.0% | kr1.6b | kr10.57 | PS9.5x | E101.6% | n/a | ||
IMU | US$28.74 | 6.8% | 615.5% | US$8.4b | US$26.83 | PS29.1x | E45.9% | n/a | ||
IDDA | €2.08 | -1.0% | -13.3% | €178.3m | €5.91 | PS2.9x | E33.0% | n/a | ||
7UX | kr0.028 | 10.2% | -55.2% | kr82.7m | n/a | PS13.9x | E54.4% | n/a | ||
51KB | US$1.63 | -2.4% | -43.0% | US$216.7m | US$5.02 | PS4.3x | E62.0% | n/a | ||
G1H | US$3.43 | -11.1% | 23.9% | US$197.2m | US$7.74 | PS2.4x | E55.1% | n/a | ||
P0F | kr0.44 | 0% | n/a | kr1.9b | n/a | PS32.4x | E85.4% | n/a | ||
328 | US$4.50 | 0.4% | -0.4% | US$313.8m | US$19.92 | PS22.4x | E52.8% | n/a | ||
08D | US$23.00 | 2.7% | -5.7% | US$1.2b | US$44.80 | PS6.3x | E65.6% | n/a | ||
BIX0 | kr2.11 | 6.5% | -13.2% | kr1.7b | kr6.74 | PS28x | E81.6% | n/a | ||
1RV | US$36.00 | -5.3% | 118.2% | US$2.4b | US$51.91 | PS31.3x | E60.9% | n/a | ||
AB3A | US$119.70 | 3.0% | 7.3% | US$12.0b | US$155.50 | PS9.6x | E42.6% | n/a | ||
DR6 | US$15.85 | 1.8% | -17.5% | US$2.8b | US$27.30 | PS3.8x | E40.9% | n/a | ||
NB11 | US$3.81 | 0% | -36.9% | US$541.2m | US$10.15 | PS1150.5x | E76.0% | n/a | ||
2CX | US$51.89 | -0.9% | 79.0% | US$3.7b | US$51.90 | PS100.3x | E69.1% | n/a | ||
O2T | US$36.00 | -0.6% | 226.4% | US$5.5b | US$36.05 | PB11.6x | E59.0% | n/a | ||
I5X | US$1.30 | -1.5% | 25.2% | US$328.6m | US$8.88 | PS52.8x | E55.5% | n/a | ||
8JD | €3.89 | 0.4% | 22.7% | €64.8m | €9.53 | PS9.5x | E87.5% | n/a | ||
1ZLB | US$1.49 | 5.7% | -46.8% | US$1.6b | US$4.95 | PS5.8x | E62.0% | n/a | ||
1AEA | €346.00 | 0% | -1.7% | €20.8b | €433.30 | PS17.5x | E56.1% | n/a |